O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Aisner, D. L., Menter, A. R., . . . Messersmith, W. A. (2016). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol.
Style de citation ChicagoO'Neil, B. H., et al. "A Phase II/III Randomized Study to Compare the Efficacy and Safety of Rigosertib Plus Gemcitabine Versus Gemcitabine Alone in Patients With Previously Untreated Metastatic Pancreatic Cancer." Ann Oncol 2016.
Style de citation MLAO'Neil, B. H., et al. "A Phase II/III Randomized Study to Compare the Efficacy and Safety of Rigosertib Plus Gemcitabine Versus Gemcitabine Alone in Patients With Previously Untreated Metastatic Pancreatic Cancer." Ann Oncol 2016.